Perry Ellis International Inc. (NASDAQ:PERY) is executing on the company’s turnaround, according to Benchmark Co.’s beliefs. The firm maintains a Buy rating but raised its price target on shares.
Don’t Miss: Did Google Just Put Apple to SHAME?
Orbitz Worldwide, Inc. (NYSE:OWW): According to Benchmark Co., Orbits Worldwide shares provide great value and important potential for an upside at current levels. The firm predicts that travel demand stayed strong in May and June although the global economic slowdown was prevalent, and the firm maintains a Buy rating and $6 price target on the stock.
Cogent Communications Group Inc. (NASDAQ:CCOI) is one of the main suppliers of Netflix’s (NASDAQ:NFLX) Open Connect content delivery network’s bandwidth, William Blair says. The firm also states that Akamai (NASDAQ:AKAM), Limelight (NASDAQ:LLNW), and Level 3 (NASDAQ:LVLT) were previously used for CDN connectivity, but it currently moves toward in-house solutions. William Balir views Netflix as a great opportunity for Cogent and it maintains an Outperform rating on the stock.
The Goldman Sachs Group, Inc. (NYSE:GS) Q2 estimates were lowered by Citi due to weak trading results; Morgan Stanley (NYSE:MS), Bank of America (NYSE:BAC), and JPMorgan (NYSE:JPM) were also lowered by Citi. The firm lowered Goldman estimates from $2.70 from 80c, Morgan Stanley from 51c to 31c, Bank of America from 19c to 12c, and JPMorgan was lowered from 87c to 79c. Also, to reflect the recent economic challenges and regulatory headwinds, Citi dropped its estimates for 2013 and 2014 by 15%. Citi also dropped the price targets for the above listed firms as follows; Goldman Sachs to $110 from $145, Morgan Stanley to $16 from $20, Bank of America to $8 from $9, and JPMorgan to $43 from $45. Citi maintains a Buy rating on Goldman and JPMorgan, while JPMorgan stays its top pick.
Amarin Corporation plc (NASDAQ:AMRN): Following the United States Patent and Trademark Office’s positive actions regarding three Amarin MARINE patents, Jefferies claims that a fourth Marine patent application, ‘150, has also gotten a Reasons for Allowance update, indicating near-term issuance. Because Jefferies views this as an incremental positive, the firm maintains a Buy rating and a $26 price target on Amarin shares.
Don’t Miss: Arena Shares Skyrocket and Sink on EPIC Victory.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.